Patricia Blake named new CEO of Heart Rhythm Society

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

Blake has spent the past 16 years as the CEO of the American Society for Gastrointestinal Endoscopy (ASGE), helping grow the organization from 8,000 to 15,000 members. She also oversaw ASGE’s operating budget increase from $4 million to $17 million during that timeframe.

Patricia Blake
Patricia Blake

Prior to her tenure there, Blake held leadership roles with the American Academy of Neurology and the Emergency Nurses Association.

“The Search Committee found Pat’s background in leading transformational change especially compelling because it tracks so closely with what we have experienced at HRS,” stated the announcement, which was signed by Thomas F. Deering, MD, MBA, president of HRS; and Michael R. Gold, MD, PhD, the chair of the CEO search committee.

“Certainly, her career success reflects strong strategic capability, inspirational team leadership, and the ability to build relationships with a wide variety of stakeholders, including multiple disciplines within the GI field and external partners. … We are confident that she will help HRS build on its current success and forge a path towards an even brighter future.”

The HRS represents professionals who specialize in cardiac rhythm disorders from more than 70 countries.

""

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.